About Acusense
Acusense BioMedical Technology Co., Ltd.
Founded in 2017, we are committed to developing innovative medical solutions using cutting-edge Artificial Intelligence (AI) and Internet of Things (IoT) technologies. Our core goal is to improve clinical efficiency, patient safety, and overall healthcare quality.
AcuSense BioMedical Technology Co., Ltd. Founded in 2017, we are committed to developing innovative medical solutions using cutting-edge Artificial Intelligence (AI) and Internet of Things (IoT) technologies. Our core goal is to improve clinical efficiency, patient safety, and overall healthcare quality.
2025.05
Selected by Startup Terrace to attend the CEE Mission in Poland
2025.01
Attended CES 2025 in Las Vegas
2024.10
Launched the POC project for smart hospital wards in three public hospitals
2024.10
Attended GITEX in Dubai
2023.06
Signed an MOU with IKEM, the largest medical research center in the Czech
2023.03
Selected by Czech Accelerator Caelestinus Healthtech Incubator
2022.11
Attended the MEDICA in Düsseldorf, Germany and the medical device industry visit in Prague, Czech Republic
2022.09
Passed the NSTC x MEDICA 2022 selection
2021.12
Shortlisted in the top ten of Qualcomm Taiwan Innovation Competition
2021.08
Tainan Municipal Annan Hospital clinical trial approved [IRB number: TMANHIIO· C024]
2021.07
Shortlisted for the 9th Clouded Leopard Training Program, and worked with Lingqun Computer
2021.05
3rd IEEE ECBIOS 2021 Best Conference Paper (two papers)
2021.01
Selected as TAcc Propel Accelerator Team by the SME Department
2020.06
European Association of Nephrology (ERA-EDTA 2020) clinical research results published
2020.04
MIT COVID-19 Hackathon challenge potential proposal
2020.04
Launched overseas strategic alliance with Hugui Xingye × Zhengmei Group
2020.02
BE Accelerator selected team
2019.12
The 16th National Innovation Award
2019.11
